Cargando…
RNA therapeutics
“RNA therapeutics” refers to a disease treatment or drug that utilizes RNA as a component. In this context, RNA may be the direct target of a small-molecule drug or RNA itself may be the drug, designed to bind to a protein, or to mimic or target another RNA. RNA has gained attention in the drug-deve...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019368/ https://www.ncbi.nlm.nih.gov/pubmed/36928165 http://dx.doi.org/10.1261/rna.079626.123 |
_version_ | 1784908012915261440 |
---|---|
author | Hastings, Michelle L. Krainer, Adrian R. |
author_facet | Hastings, Michelle L. Krainer, Adrian R. |
author_sort | Hastings, Michelle L. |
collection | PubMed |
description | “RNA therapeutics” refers to a disease treatment or drug that utilizes RNA as a component. In this context, RNA may be the direct target of a small-molecule drug or RNA itself may be the drug, designed to bind to a protein, or to mimic or target another RNA. RNA has gained attention in the drug-development world, as recent clinical successes and breakthrough technologies have revolutionized the drug-like qualities of the molecule or its usefulness as a drug target. In this special issue of RNA, we gathered expert perspectives on the past, present, and future of the field, to serve as a primer and also a challenge to the broad scientific community to incorporate RNA into their experimental design and problem-solving process, and to imagine and realize the potential of RNA as a therapeutic drug or target. |
format | Online Article Text |
id | pubmed-10019368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-100193682023-04-01 RNA therapeutics Hastings, Michelle L. Krainer, Adrian R. RNA Introduction “RNA therapeutics” refers to a disease treatment or drug that utilizes RNA as a component. In this context, RNA may be the direct target of a small-molecule drug or RNA itself may be the drug, designed to bind to a protein, or to mimic or target another RNA. RNA has gained attention in the drug-development world, as recent clinical successes and breakthrough technologies have revolutionized the drug-like qualities of the molecule or its usefulness as a drug target. In this special issue of RNA, we gathered expert perspectives on the past, present, and future of the field, to serve as a primer and also a challenge to the broad scientific community to incorporate RNA into their experimental design and problem-solving process, and to imagine and realize the potential of RNA as a therapeutic drug or target. Cold Spring Harbor Laboratory Press 2023-04 /pmc/articles/PMC10019368/ /pubmed/36928165 http://dx.doi.org/10.1261/rna.079626.123 Text en © 2023 Hastings and Krainer; Published by Cold Spring Harbor Laboratory Press for the RNA Society https://creativecommons.org/licenses/by-nc/4.0/This article, published in RNA, is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Introduction Hastings, Michelle L. Krainer, Adrian R. RNA therapeutics |
title | RNA therapeutics |
title_full | RNA therapeutics |
title_fullStr | RNA therapeutics |
title_full_unstemmed | RNA therapeutics |
title_short | RNA therapeutics |
title_sort | rna therapeutics |
topic | Introduction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019368/ https://www.ncbi.nlm.nih.gov/pubmed/36928165 http://dx.doi.org/10.1261/rna.079626.123 |
work_keys_str_mv | AT hastingsmichellel rnatherapeutics AT kraineradrianr rnatherapeutics |